CELCUITY INC (CELC) — insider trading
Health Care · NASDAQ
CELCUITY INC (CELC) has 33 reported SEC Form 4 insider transactions in our data, including 9 open-market sales among the most recent 33 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | GRYSKA DAVID W | Director | Grant / award / vesting | 893 | — | $0 | Form 4 |
| 2026-08-14 | Hahne Vicky | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 10,000 | — | $0 | Form 4 |
| 2026-08-14 | Hahne Vicky | Officer (Chief Financial Officer) | Grant / award / vesting | 16,000 | — | $0 | Form 4 |
| 2026-08-14 | Sullivan Brian F. | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 120,000 | — | $0 | Form 4 |
| 2026-08-14 | Sullivan Brian F. | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 80,000 | — | $0 | Form 4 |
| 2026-08-14 | Laing Lance G. | Director, Officer (Chief Science Officer) | Grant / award / vesting (derivative) | 10,000 | — | $0 | Form 4 |
| 2026-08-14 | Laing Lance G. | Director, Officer (Chief Science Officer) | Grant / award / vesting | 20,000 | — | $0 | Form 4 |
| 2026-07-14 | BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN | Other | Open-market sale | 2,838,632 | $102.50 | $290.96M | Form 4 |
| 2026-07-14 | BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN | Other | Open-market sale | 261,368 | $102.50 | $26.79M | Form 4 |
| 2026-06-10 | Buller Richard E | Director | Bona fide gift (derivative) | 12,503 | — | $0 | Form 4 |
| 2026-06-10 | Buller Richard E | Director | Bona fide gift (derivative) | 12,503 | — | $0 | Form 4 |
| 2026-06-10 | Murphy Polly A. | Director | Bona fide gift (derivative) | 14,048 | — | $0 | Form 4 |
| 2026-06-10 | Murphy Polly A. | Director | Bona fide gift (derivative) | 14,048 | — | $0 | Form 4 |
| 2026-06-05 | Buller Richard E | Director | Grant / award / vesting | 1,530 | — | $0 | Form 4 |
| 2026-06-05 | Furcht Leo | Director | Grant / award / vesting | 1,530 | — | $0 | Form 4 |
| 2026-06-05 | NIGON RICHARD | Director | Grant / award / vesting | 1,530 | — | $0 | Form 4 |
| 2026-06-05 | ROMP CHARLES R | Director | Grant / award / vesting | 1,530 | — | $0 | Form 4 |
| 2026-06-05 | Dalvey David | Director | Grant / award / vesting | 1,530 | — | $0 | Form 4 |
| 2026-06-05 | Murphy Polly A. | Director | Grant / award / vesting | 1,530 | — | $0 | Form 4 |
| 2026-06-02 | Laing Lance G. | Director, Officer (Chief Science Officer) | Option exercise / conversion (derivative) | 1,000 | — | $0 | Form 4 |
| 2026-06-02 | Laing Lance G. | Director, Officer (Chief Science Officer) | Option exercise / conversion | 1,000 | $9.89 | $9.9K | Form 4 |
| 2026-05-19 | Buller Richard E | Director | Bona fide gift | 1,029 | — | $0 | Form 4 |
| 2026-05-19 | Buller Richard E | Director | Bona fide gift | 1,029 | — | $0 | Form 4 |
| 2026-05-04 | Buller Richard E | Director | Option exercise / conversion (derivative) | 9,000 | — | $0 | Form 4 |
| 2026-05-04 | Buller Richard E | Director | Open-market sale | 365 | $143.24 | $52.3K | Form 4 |
| 2026-05-04 | Buller Richard E | Director | Open-market sale | 2,825 | $142.04 | $401.3K | Form 4 |
| 2026-05-04 | Buller Richard E | Director | Open-market sale | 2,301 | $141.03 | $324.5K | Form 4 |
| 2026-05-04 | Buller Richard E | Director | Open-market sale | 1,670 | $139.58 | $233.1K | Form 4 |
| 2026-05-04 | Buller Richard E | Director | Open-market sale | 550 | $139.00 | $76.4K | Form 4 |
| 2026-05-04 | Buller Richard E | Director | Open-market sale | 1,289 | $137.00 | $176.6K | Form 4 |
| 2026-05-04 | Buller Richard E | Director | Option exercise / conversion | 9,000 | $5.10 | $45.9K | Form 4 |
| 2026-05-04 | Dalvey David | Director | Open-market sale | 25,000 | $140.68 | $3.52M | Form 4 |
| 2026-04-09 | NIGON RICHARD | Director | Bona fide gift | 10,000 | — | $0 | Form 4 |
Ask the chat about CELC's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CELCUITY INC (CELC).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.